title: Response to Giannelli et al.--comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
abstract: Some comments have been done on an article describing a pilot trial evaluating the potential use of moxidectin contained in a spot-on formulation in the prevention of canine filarioses in a confined area where the three major canine filariae live in sympatry. We herein present our response to these comments.
authors.affiliation: Faculty of Veterinary Medicine, University of Teramo, Teramo, Italy, dtraversa@unite.it.
authors.forename: Donato
authors.initials: D
authors.lastname: Traversa
authors.forename: Paolo
authors.initials: P
authors.lastname: Famigli Bergamini
authors.forename: Federico
authors.initials: F
authors.lastname: Fracassi
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Pampurini
authors.forename: Andrea
authors.initials: A
authors.lastname: Boari
mesh_terms: D000818:Animals; D000969:Antinematodal Agents / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D005368:Filariasis / Q000188:drug therapy* / Q000517:prevention & control*; D007093:Imidazoles / Q000627:therapeutic use*; D018942:Macrolides / Q000627:therapeutic use*; D009574:Nitro Compounds / Q000627:therapeutic use*
chemical_list: D000969:Antinematodal Agents; D007093:Imidazoles; D018942:Macrolides; D009574:Nitro Compounds